Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria (Q61908599)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

title

Effect of high-dose tyrosine supplementation on brain function in adults with phenylketonuria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

Leo de Sonneville

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

J Pietz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

A Kutscha

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

H Schmidt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

F K Trefz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

language of work or name

English

0 references

publication date

1 December 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

127

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

936-943

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

Intellectual development in 12-year-old children treated for phenylketonuria

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Neurological deterioration in young adults with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Phenylketonuria: MR imaging of the brain with clinical correlation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Magnetic resonance imaging of the brain in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Phenylalanine alters the mean power frequency of electroencephalograms and plasma L-dopa in treated patients with phenylketonuria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

EEGs in phenylketonuria. I: Follow-up to adulthood; II: Short-term diet-related changes in EEGs and cognitive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Extracorporeal enzyme reactors for depletion of phenylalanine in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Valine, isoleucine, and leucine. A new treatment for phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Unsuccessful treatment of phenylketonuria with tyrosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Large doses of tryptophan and tyrosine as potential therapeutic alternative to dietary phenylalanine restriction in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Increased Vigilance and Dopamine Synthesis by Large Doses of Tyrosine or Phenylalanine Restriction in Phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Increased neurotransmitter biosynthesis in phenylketonuria induced by phenylalanine restriction or by supplementation of unrestricted diet with large amounts of tyrosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Pathogenesis of phenylketonuria: Inhibition of dopa and catecholamine synthesis in patients with phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Role of precursor availability in control of monoamine biosynthesis in brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Early-treated phenylketonuria: adult neuropsychologic outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Neuropsychology of early-treated phenylketonuria: specific executive function deficits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

An animal model of early-treated PKU.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Pattern evoked potentials in phenylketonuria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Measurements of visual evoked potentials in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Effect of levodopa on the human pattern electroretinogram and pattern visual evoked potentials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

EEG mean frequencies are sensitive indices of phenylalanine effects on normal brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

The effects of high phenylalanine concentrations on serotinin and catecholamine metabolism in the human brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

Postmortem changes of amino compounds in human and rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2895%2970031-5

10.1016/S0022-3476(95)70031-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8523192%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference